Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

British Journal of Cancer (117)
Bone Marrow Transplantation (83)
Leukemia (29)
Nature (23)
European Journal of Clinical Nutrition (6)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (233)
Reviews (23)
Correspondence (9)
News (4)
Amendments and Corrections (3)
Special Features (3)
Books & Arts (1)
News & Views (1)

Subject Check one or more subjects to show results from those subjects only.

Biological techniques
Biomarkers
Cancer
Chemical biology
Chemistry
Computational biology and bioinformatics
Developmental biology
Diseases
Drug discovery
Genetics
Health care
Immunology
Medical research
Molecular biology
Oncology
Pathogenesis
Risk factors
Social policy
Social sciences
Stem cells

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 151–200 of 277 results

Advanced filters: Author: R. POWLES Clear advanced filters

Hypertension and aging in rural Haiti: results from a preliminary survey

V B Polsinelli
N Satchidanand
J L Izzo Jr
Research28 Jul 2016
Journal of Human Hypertension

Volume: 31, P: 138-144
Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients

A A Ezzat
E M Ibrahim
R Sorbris
ResearchOpen Access02 Mar 2004
British Journal of Cancer

Volume: 90, P: 968-974
Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma

S Jagannath
DH Vesole
B Barlogie
Research01 Sept 1997
Bone Marrow Transplantation

Volume: 20, P: 445-450
Does it matter where you live? Treatment variation for breast cancer in Yorkshire

R Sainsbury
L Rider
A MacAdam
Research01 Jun 1995
British Journal of Cancer

Volume: 71, P: 1275-1278
Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts

E Jacobs
S A Watson
J F R Robertson
ResearchOpen Access09 Apr 1999
British Journal of Cancer

Volume: 80, P: 352-359
High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study

DA Cameron
J Craig
W Miller
Research01 Dec 1996
British Journal of Cancer

Volume: 74, P: 2013-2017
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission

DS Snyder
AP Nademanee
SJ Forman
Research02 Dec 1999
Leukemia

Volume: 13, P: 2053-2058
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML

T Fischer
A Neubauer
C Huber
Research14 May 1998
Bone Marrow Transplantation

Volume: 21, P: 1029-1036
Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescue

S Bilgrami
N G Chakraborty
P J Tutschka
Research26 Feb 1999
Bone Marrow Transplantation

Volume: 23, P: 469-474
Differential effects of cyclosporin A on the alloreactivity of fresh and ex vivo-expanded T lymphocytes

E Contassot
E Robinet
P Tiberghien
Research03 Dec 1998
Bone Marrow Transplantation

Volume: 22, P: 1097-1102
Prognosis in bilateral breast cancer. Effects of time interval between first and second primary tumours

L Holmberg
HO Adami
A Lindgren
Research01 Aug 1988
British Journal of Cancer

Volume: 58, P: 191-194
Simultaneous detection of X and Y chromosomes by two-colour fluorescence in situ hybridization in combination with immunophenotyping of single cells to document chimaerism after sex-mismatched bone marrow transplantation

MJD van Tol
R Langlois van den Bergh
HJ Tanke
Research12 Mar 1998
Bone Marrow Transplantation

Volume: 21, P: 497-503
Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoring

H M-L Ball
T R Hupp
A M Thompson
ResearchOpen Access16 Oct 2001
British Journal of Cancer

Volume: 85, P: 1102-1105
The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer

M Dowsett
J S Tobias
M Baum
ResearchOpen Access18 Dec 1998
British Journal of Cancer

Volume: 79, P: 311-315
Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells

G Visani
RM Lemoli
S Tura
Research08 Sept 1999
Bone Marrow Transplantation

Volume: 24, P: 467-472
Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity

H Bertz
K Potthoff
J Finke
Research01 Jun 1997
Bone Marrow Transplantation

Volume: 19, P: 1169-1173
Iron depletion by phlebotomy with recombinant erythropoietin prior to allogeneic transplantation to prevent liver toxicity

J de la Serna
R Bornstein
J-J Lahuerta-Palacios
Research22 Dec 1998
Bone Marrow Transplantation

Volume: 23, P: 95-97
Isolated extramedullary relapse of acute lymphoblastic leukaemia after allogeneic bone marrow transplantation

WY Au
AKW Lie
YL Kwong
Research10 Nov 1999
Bone Marrow Transplantation

Volume: 24, P: 1137-1140
Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin’s lymphoma

M Bernard
C Dauriac
T Lamy
Research12 Feb 1999
Bone Marrow Transplantation

Volume: 23, P: 329-333
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma

S Kumar
M Q Lacy
M A Gertz
Research02 Aug 2004
Bone Marrow Transplantation

Volume: 34, P: 485-490
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy

S Kumar
M Q Lacy
M A Gertz
Research10 May 2004
Bone Marrow Transplantation

Volume: 34, P: 161-167
Phloem fortification in rye bread elevates serum enterolactone level

M Vanharanta
J Mursu
JT Salonen
Research24 Sept 2002
European Journal of Clinical Nutrition

Volume: 56, P: 952-957
The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies

R R Huxley
H A W Neil
Research24 Jul 2003
European Journal of Clinical Nutrition

Volume: 57, P: 904-908
Impact of additional cytoreduction following autologous SCT in multiple myeloma

S K Kumar
D Dingli
M A Gertz
Research16 Jun 2008
Bone Marrow Transplantation

Volume: 42, P: 259-264
Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma

R L Jones
S R Lakhani
I E Smith
ResearchOpen Access17 Jan 2006
British Journal of Cancer

Volume: 94, P: 358-362
A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred Diethylstilbestrol

J Shamash
T Powles
T Oliver
ResearchOpen Access01 Feb 2011
British Journal of Cancer

Volume: 104, P: 620-628
Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom

J E Lester
D Dodwell
R E Coleman
ResearchOpen Access29 Nov 2005
British Journal of Cancer

Volume: 94, P: 30-35
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

J J Body
I J Diel
B Bergstrom
ResearchOpen Access24 Feb 2004
British Journal of Cancer

Volume: 90, P: 1133-1137
Tamoxifen induction of angiogenic factor expression in endometrium

S Hague
S Manek
M C P Rees
ResearchOpen Access26 Feb 2002
British Journal of Cancer

Volume: 86, P: 761-767
Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer

N R Jagannathan
M Kumar
G K Rath
ResearchOpen Access17 Apr 2001
British Journal of Cancer

Volume: 84, P: 1016-1022
High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration

P Benedetti Panici
L Pierelli
S Mancuso
Research01 Apr 1997
British Journal of Cancer

Volume: 75, P: 1205-1212
Metabolic effects of pamidronate in patients with metastatic bone disease

J Vinholes
C-Y Guo
RE Coleman
Research01 May 1996
British Journal of Cancer

Volume: 73, P: 1089-1095
A prognostic index for multiple myeloma

G Grignani
PG Gobbi
E Ascari
Research01 May 1996
British Journal of Cancer

Volume: 73, P: 1101-1107
A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

H B Hewitt
E R Blake
A S Walder
Research01 Mar 1976
British Journal of Cancer

Volume: 33, P: 241-259
Cyclosporin A and doxorubicin-ifosfamide in resistant solid tumours: a phase I and an immunological study

R González-Manzano
J Cid
CC Piasecki
Research01 Nov 1995
British Journal of Cancer

Volume: 72, P: 1294-1299
Inhibition of growth of human leukemia cell lines by retrovirally expressed wild-type p16^INK4A

AF Gombart
R Yang
HP Koeffler
Research01 Oct 1997
Leukemia

Volume: 11, P: 1673-1680
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study

A Riccardi
O Mora
E Ascari
ResearchOpen Access07 Mar 2000
British Journal of Cancer

Volume: 82, P: 1254-1260
The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties

JM Chessells
E Hall
SM Richards
Research08 May 1998
Leukemia

Volume: 12, P: 463-473
Enhanced expression of p16^ink4a is associated with a poor prognosis in childhood acute lymphoblastic leukemia

Y Mekki
R Catallo
M Ffrench
Research05 Feb 1999
Leukemia

Volume: 13, P: 181-189
The adjuvant treatment of kidney cancer: a multidisciplinary outlook

Effective adjuvant therapies are needed to reduce the risk of recurrence of kidney cancer. Here, the authors discuss the results of adjuvant therapy trials, the potential of immune checkpoint inhibitors as adjuvant therapies and the need for multidisciplinary management of patients with resected kidney cancer.

Camillo Porta
Laura Cosmai
Axel Bex
Reviews26 Mar 2019
Nature Reviews Nephrology

Volume: 15, P: 423-433
Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone

A Alegre
JF Tomás
JM Fernández-Rañada
Research01 Aug 1997
Bone Marrow Transplantation

Volume: 20, P: 211-217
The proliferation of multiple myeloma colonies (MY-CFUc) in vitro is independent of prognosis and is not associated with mutated N- or K-ras alleles in human bone marrow aspirates

BC Millar
JBG Bell
M Everard
Research01 Feb 1995
British Journal of Cancer

Volume: 71, P: 259-264
Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry

A Alegre
J Díaz-Mediavilla
JM Fernández-Rañada
Research18 Feb 1998
Bone Marrow Transplantation

Volume: 21, P: 133-140
Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort

C Foster
D G R Evans
M Watson
ResearchOpen Access16 Apr 2002
British Journal of Cancer

Volume: 86, P: 1209-1216
Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience

RM Lowenthal
C Fabères
J Reiffers
Research09 Oct 1998
Bone Marrow Transplantation

Volume: 22, P: 763-770
A low CD34⁺ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 10⁶ CD34⁺ cells/kg be considered the minimum threshold?

S Singhal
R Powles
J Mehta
Research31 Aug 2000
Bone Marrow Transplantation

Volume: 26, P: 489-496
Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer

C D Archer
M Parton
M Dowsett
ResearchOpen Access09 Sept 2003
British Journal of Cancer

Volume: 89, P: 1035-1041
Psychosocial impact of breast/ovarian (BRCA 1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort

M Watson
C Foster
D G R Evans
ResearchOpen Access26 Oct 2004
British Journal of Cancer

Volume: 91, P: 1787-1794
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)

S Giralt
E A Stadtmauer
B G M Durie
Research25 Jun 2009
Leukemia

Volume: 23, P: 1904-1912
Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia

C DeLord
J Treleaven
R L Powles
Research26 Feb 1999
Bone Marrow Transplantation

Volume: 23, P: 523-525